DAFNA Capital Management as of Sept. 30, 2021
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 80 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 19.5 | $74M | 14M | 5.38 | |
| Blueprint Medicines (BPMC) | 5.6 | $21M | 207k | 102.81 | |
| Fate Therapeutics (FATE) | 5.4 | $20M | 344k | 59.27 | |
| Biohaven Pharmaceutical Holding | 3.2 | $12M | 88k | 138.91 | |
| Dicerna Pharmaceuticals | 3.1 | $12M | 588k | 20.16 | |
| Ideaya Biosciences (IDYA) | 3.1 | $12M | 460k | 25.49 | |
| Dex (DXCM) | 3.1 | $12M | 21k | 546.88 | |
| Morphic Hldg (MORF) | 2.7 | $10M | 182k | 56.64 | |
| Nurix Therapeutics (NRIX) | 2.4 | $9.2M | 306k | 29.96 | |
| Karuna Therapeutics Ord | 2.4 | $9.1M | 75k | 122.33 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $8.1M | 85k | 95.91 | |
| Sage Therapeutics (SAGE) | 2.1 | $8.0M | 180k | 44.31 | |
| Arena Pharmaceuticals Com New | 1.9 | $7.1M | 120k | 59.55 | |
| Ishares Tr Nasdaq Biotech Etf (IBB) | 1.8 | $6.6M | 41k | 161.69 | |
| Cardiovascular Systems | 1.7 | $6.4M | 194k | 32.83 | |
| Cytokinetics Com New (CYTK) | 1.7 | $6.3M | 175k | 35.74 | |
| Xenon Pharmaceuticals (XENE) | 1.6 | $6.2M | 407k | 15.28 | |
| Affimed Therapeutics B V | 1.6 | $6.0M | 965k | 6.18 | |
| Revolution Medicines (RVMD) | 1.5 | $5.8M | 210k | 27.51 | |
| F-star Therapeutics | 1.3 | $5.1M | 694k | 7.32 | |
| AtriCure (ATRC) | 1.3 | $5.0M | 72k | 69.56 | |
| Otonomy | 1.2 | $4.6M | 2.4M | 1.92 | |
| Arcus Biosciences Incorporated (RCUS) | 1.1 | $4.3M | 124k | 34.87 | |
| Galapagos Nv Spon Adr (GLPG) | 1.1 | $4.1M | 78k | 52.60 | |
| Accuray Incorporated (ARAY) | 1.0 | $3.7M | 942k | 3.95 | |
| Radius Health Note 3.000% 9/0 (Principal) | 1.0 | $3.6M | 4.0M | 0.91 | |
| Iveric Bio | 0.9 | $3.5M | 216k | 16.24 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $3.3M | 189k | 17.45 | |
| Aerie Pharmaceuticals | 0.9 | $3.3M | 289k | 11.40 | |
| Fs Development Corp Ii Com Cl A | 0.8 | $3.0M | 300k | 9.95 | |
| Adicet Bio (ACET) | 0.8 | $3.0M | 376k | 7.84 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.8 | $2.9M | 809k | 3.63 | |
| Merus N V (MRUS) | 0.8 | $2.9M | 132k | 22.00 | |
| Viking Therapeutics (VKTX) | 0.7 | $2.8M | 447k | 6.28 | |
| Venus Concept | 0.7 | $2.8M | 1.1M | 2.51 | |
| Turning Point Therapeutics I | 0.7 | $2.8M | 42k | 66.43 | |
| Kadmon Hldgs | 0.7 | $2.7M | 315k | 8.71 | |
| Mereo Biopharma Group Ads (MREO) | 0.7 | $2.7M | 1.1M | 2.42 | |
| 89bio (ETNB) | 0.7 | $2.5M | 127k | 19.59 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.7 | $2.5M | 296k | 8.37 | |
| Alector (ALEC) | 0.7 | $2.5M | 107k | 22.82 | |
| Kinnate Biopharma (KNTE) | 0.7 | $2.5M | 107k | 23.02 | |
| Natus Medical | 0.6 | $2.4M | 96k | 25.08 | |
| Iteos Therapeutics (ITOS) | 0.6 | $2.2M | 83k | 27.00 | |
| Neuronetics (STIM) | 0.5 | $2.1M | 314k | 6.56 | |
| Century Therapeutics (IPSC) | 0.5 | $2.0M | 80k | 25.16 | |
| Cymabay Therapeutics | 0.5 | $1.9M | 524k | 3.65 | |
| Hookipa Pharma Inc equity (HOOK) | 0.5 | $1.9M | 322k | 5.89 | |
| Kura Oncology (KURA) | 0.5 | $1.9M | 101k | 18.73 | |
| Macrogenics (MGNX) | 0.5 | $1.9M | 90k | 20.94 | |
| Cogent Biosciences (COGT) | 0.5 | $1.9M | 224k | 8.41 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.5 | $1.9M | 603k | 3.11 | |
| Mei Pharma Com New | 0.5 | $1.8M | 641k | 2.76 | |
| Brainway Sponsored Ads (BWAY) | 0.4 | $1.6M | 200k | 8.06 | |
| Sutro Biopharma (STRO) | 0.4 | $1.6M | 85k | 18.89 | |
| Field Trip Health Ord | 0.4 | $1.6M | 341k | 4.59 | |
| Inflarx Nv (IFRX) | 0.4 | $1.6M | 600k | 2.59 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $1.5M | 81k | 19.11 | |
| Athira Pharma (ATHA) | 0.4 | $1.5M | 161k | 9.38 | |
| Ngm Biopharmaceuticals (NGM) | 0.4 | $1.4M | 66k | 21.01 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.4 | $1.4M | 1.5M | 0.92 | |
| Mersana Therapeutics (MRSN) | 0.4 | $1.3M | 140k | 9.43 | |
| Aslan Pharmaceuticals Ads | 0.3 | $1.3M | 733k | 1.78 | |
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.3M | 100k | 12.65 | |
| Nextcure (NXTC) | 0.3 | $1.2M | 184k | 6.74 | |
| Compugen Ord (CGEN) | 0.3 | $1.2M | 202k | 5.97 | |
| Alpine Immune Sciences (ALPN) | 0.3 | $1.2M | 112k | 10.67 | |
| Harpoon Therapeutics | 0.2 | $831k | 105k | 7.90 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $825k | 139k | 5.92 | |
| Masimo Corporation (MASI) | 0.2 | $812k | 3.0k | 270.67 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $808k | 236k | 3.42 | |
| Larimar Therapeutics (LRMR) | 0.2 | $744k | 65k | 11.54 | |
| Genfit S A Ads (GNFT) | 0.2 | $698k | 189k | 3.70 | |
| Inogen (INGN) | 0.2 | $646k | 15k | 43.07 | |
| Rti Biologics | 0.2 | $632k | 580k | 1.09 | |
| Pharvaris N V (PHVS) | 0.2 | $622k | 35k | 17.73 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $447k | 5.6k | 79.82 | |
| Annexon (ANNX) | 0.1 | $434k | 23k | 18.63 | |
| Radius Health Com New | 0.0 | $180k | 15k | 12.41 | |
| Vascular Biogenics | 0.0 | $113k | 55k | 2.05 |
